Corticosteroids have been used to treat a variety of lung diseases since the early 1950s,
when the benefits of oral cortisone were first reported both for hay fever and asthma induced …

Most guidelines presently recommend high-dose inhaled steroids (1000 µLg/d or more) as
first-line maintenance therapy for moderate to severe asthma. Numerous studies have …

Asthma has been a major disease focus for the past 7 years due to the increasing morbidity
and mortality. In 1991, the National Asthma Education and Prevention Program (NAEPP) …

Pulmonary diseases such as Chronic Obstructive Pulmonary Disease (COPD) and asthma
are common in the elderly population. Corticosteroids, systemic and inhaled, are commonly …

Since the initial identification of corticosteroids as effective treatment for asthma (1–3),
inhaled corticosteroids have evolved into the most important and useful drugs currently …

For many years, effective therapy for the management of asthma has been available. Issues
of adverse side effects and questionable patient compliance with current therapies have …

Bei der Durchsicht des umfangreichen Schrifttums über Nebenwirkungen inhalativer
Glukokortikoide fällt auf, daß die Ergebnisse der Cumming-Studie selbst in methodisch …

The incidence of drug-induced adverse effects is likely to increase as a result of advanced
age and exposure of elderly patients to polypharmacy. Therefore, pharmacological therapy …

Study objective: To evaluate the prevalence of posterior subcapsular cataracts (PSCC) in
asthmatic patients receiving corticosteroid therapy Design: The cases were examined by the …

In einer Re-Analyse der Blue Mountains Eye Study von Cumming, Mitchell und Leeder
(1997) wird gezeigt, daß diese Studie keinen Beitrag zur Klärung des Kataraktrisikos von …